Lataa...
Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications
Diabetes is a leading cause of cardiovascular morbidity and mortality. Despite numerous treatments for cardiovascular disease (CVD), for patients with diabetes, these therapies provide less benefit for protection from CVD. These considerations spur the concept that diabetes-specific, disease-modifyi...
Tallennettuna:
| Julkaisussa: | Front Endocrinol (Lausanne) |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7992003/ https://ncbi.nlm.nih.gov/pubmed/33776930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.636267 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|